Department of Transplantation Immunology, University of Heidelberg, Heidelberg, Germany.
Transplantation. 2011 Jan 15;91(1):65-9. doi: 10.1097/tp.0b013e3181fa94d6.
Bone fractures are a frequent complication after kidney transplantation, for which various predisposing factors have been identified. It has been suggested that human leukocyte antigen (HLA) mismatch increases the risk.
Data on hip fractures occurring in the first 5 years posttransplant were analyzed among kidney transplants from deceased donors performed between 1995 and 2008 and reported to the Collaborative Transplant Study.
In the 20,509 patients analyzed, the cumulative rate of hip fracture by year 5 posttransplant was 0.85%. Cox regression analysis identified the following risk factors: female recipients aged 40 to 59 years (hazard ratio [HR] 2.26, P=0.029), female recipients 60 years or older (HR 5.14, P<0.001), male recipients 60 years or older (HR 2.39, P=0.028), and donor age more than or equal to 60 years (HR 1.75, P=0.009). Using the rate of fractures in recipients with zero HLA-DR mismatch as the reference, the risk of hip fracture increased for grafts with one HLA-DR mismatch to HR 1.85 (95% confidence interval [CI] 1.18-2.89, P=0.007) and with two HLA-DR mismatches to HR 2.24 (CI 1.25-4.02, P=0.007). There was a significant association between the number of HLA-DR mismatches and the diagnosis of osteoporosis 5 years after transplantation: one HLA-DR mismatch risk ratio 1.26 (CI 1.12-1.43, P<0.001) and two HLA-DR mismatches risk ratio 1.45 (CI 1.20-1.74, P<0.001).
The risk of hip fracture after kidney transplantation seems to be markedly exacerbated by HLA-DR mismatching. These findings add to the growing base of evidence that HLA-DR matching influences morbidity after kidney transplantation.
骨折是肾移植后的常见并发症,已有多种易患因素被确定。有人认为人类白细胞抗原(HLA)不匹配会增加风险。
分析了 1995 年至 2008 年间进行的尸肾移植患者术后 5 年内发生的髋部骨折数据,并报告给协作移植研究。
在分析的 20509 例患者中,术后 5 年内髋部骨折的累积发生率为 0.85%。Cox 回归分析确定了以下危险因素:40 至 59 岁的女性受者(风险比[HR]2.26,P=0.029)、60 岁或以上的女性受者(HR 5.14,P<0.001)、60 岁或以上的男性受者(HR 2.39,P=0.028)和供者年龄≥60 岁(HR 1.75,P=0.009)。以零 HLA-DR 不匹配受者的骨折率为参考,HLA-DR 不匹配 1 处的髋部骨折风险增加到 HR 1.85(95%置信区间[CI]1.18-2.89,P=0.007),不匹配 2 处的风险增加到 HR 2.24(CI 1.25-4.02,P=0.007)。HLA-DR 不匹配的数量与移植后 5 年骨质疏松症的诊断之间存在显著关联:1 处 HLA-DR 不匹配的风险比为 1.26(CI 1.12-1.43,P<0.001),2 处 HLA-DR 不匹配的风险比为 1.45(CI 1.20-1.74,P<0.001)。
肾移植后髋部骨折的风险似乎因 HLA-DR 不匹配而明显加剧。这些发现增加了越来越多的证据,表明 HLA-DR 匹配影响肾移植后的发病率。